Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids vs Corticosteroids + ECP for Standard Risk Grade II aGVHD
NCT03605940Phase 2Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Oct 2018
- Primary completion
- Apr 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of methoxsalen in Acute Graft-Versus-Host Disease (aGvHD), sponsored by CHRU de Nancy - Hôpital Central. Status: unknown.
02
Drugs
methoxsalen
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT03605940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03605940.